Journal article icon

Journal article

Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation

Abstract:
The Aryl Hydrocarbon Receptor (AHR) is a ligand-dependent transcription factor able to control complex transcriptional processes in several cell types, which has been correlated with various diseases, including inflammatory bowel diseases (IBD). Numerous studies have described different compounds as ligands of this receptor, like xenobiotics, natural compounds, and several host-derived metabolites. Dietary (poly)phenols have been studied regarding their pleiotropic activities (e.g., neuroprotective and anti-inflammatory), but their AHR modulatory capabilities have also been considered. However, dietary (poly)phenols are submitted to extensive metabolism in the gut (e.g., gut microbiota). Thus, the resulting gut phenolic metabolites could be key players modulating AHR since they are the ones that reach the cells and may exert effects on the AHR throughout the gut and other organs. This review aims at a comprehensive search for the most abundant gut phenolic metabolites detected and quantified in humans to understand how many have been described as AHR modulators and what could be their impact on inflammatory gut processes. Even though several phenolic compounds have been studied regarding their anti-inflammatory capacities, only 1 gut phenolic metabolite, described as AHR modulator, has been evaluated on intestinal inflammatory models. Searching for AHR ligands could be a novel strategy against IBD.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.redox.2023.102622

Authors

More by this author
Role:
Author
ORCID:
0000-0003-2513-1026
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-0139-1245
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4337-9113
More by this author
Role:
Author
ORCID:
0000-0002-5809-1924


More from this funder
Funder identifier:
10.13039/501100007601
Grant:
804229
More from this funder
Funder identifier:
10.13039/501100005855
Grant:
UIDB/04462/2020
More from this funder
Funder identifier:
10.13039/501100000781


Publisher:
Elsevier
Journal:
Redox Biology More from this journal
Volume:
61
Pages:
102622-102622
Article number:
102622
Publication date:
2023-02-01
DOI:
EISSN:
2213-2317
ISSN:
2213-2317


Language:
English
Keywords:
Pubs id:
1935592
Local pid:
pubs:1935592
Source identifiers:
W4318814825
Deposit date:
2026-06-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP